1997
DOI: 10.1016/s0024-3205(97)84352-4
|View full text |Cite
|
Sign up to set email alerts
|

The effects of AF-DX 116, a cardioselective muscarinic antagonist, on the negative inotropic action of soman, a cholinesterase inhibitor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2001
2001
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…ACh has a negative inotropic effect in addition to a negative chronotropic action and depresses norepinephrine release at adrenergic nerve terminals in the cardiovascular system via presynaptic muscarinic receptors (36,40). The positive inotropic action of AF-DX 116 is inhibited by propranolol, a b-adrenergic blocker (41). The strong positive inotropic action of AF-DX 116 in SART-stressed rats may thus be caused by an increased contraction of heart muscle due to norepinephrine release through blockage of M2 receptors at sympathetic nerve terminals.…”
Section: Discussionmentioning
confidence: 99%
“…ACh has a negative inotropic effect in addition to a negative chronotropic action and depresses norepinephrine release at adrenergic nerve terminals in the cardiovascular system via presynaptic muscarinic receptors (36,40). The positive inotropic action of AF-DX 116 is inhibited by propranolol, a b-adrenergic blocker (41). The strong positive inotropic action of AF-DX 116 in SART-stressed rats may thus be caused by an increased contraction of heart muscle due to norepinephrine release through blockage of M2 receptors at sympathetic nerve terminals.…”
Section: Discussionmentioning
confidence: 99%
“…These ligands are structural congeners, and of all the compounds tested, NGD-3350 shows the highest binding affinity to pM 2 . 16 The AS-MS-based binding experiments revealed that all the ligands show saturable single-site binding to pM 2 like the M 2 -specific control antagonist AF-DX-116 29,30 (Fig. 3B).…”
Section: Discovery Of Novel Pm 2 Achr Ligands By Screening Small-molementioning
confidence: 94%